Flagship Pioneering has already signed main offers with Pfizer and Novo Nordisk and simply acquired USD 3.6 billion in funding.
发布者:BY ULRICH QUISTGAARD,转转请注明出处:https://robotalks.cn/gsk-bets-big-on-respiratory-diseases-and-immunology-in-collaboration-with-us-venture-company/